Marea Therapeutics doses first patient in MAR002 phase 2 trial

🌐 Investing.com (Cyprus) —
Marea Therapeutics doses first patient in MAR002 phase 2 trial

AI Summary

Marea Therapeutics has dosed the first patient in its MAR002 Phase 2 trial. The update marks the beginning of patient treatment in the company's mid-stage clinical study.

Health Marea Therapeutics MAR002 Phase 2 clinical trial first patient dosed

Read original source →